Get notified when OSTX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsStanding Risk Factors
- Going Concern (unchanged) — The auditor's report includes a going concern explanatory paragraph, indicating substantial doubt about the company's ability to continue operating.
OS Therapies prices $1.40/share offering of 2.5M shares plus warrants, raising $3.5M gross for the company
Filed April 2, 2026 · ~1 min read
Key Changes
-
high
OS Therapies is offering 2,505,073 shares at $1.40 per share, each with a common warrant; pre-funded warrants for up to 1,250,893 shares are also offered.
The Offering verify on EDGAR → -
high
The company's gross proceeds from primary shares are $3.5M; net proceeds are estimated at $4.7M, which includes the over-allotment option.
Use of Proceeds verify on EDGAR → -
medium
Net proceeds will fund clinical development, R&D, potential acquisitions, and working capital.
Use of Proceeds verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MKC 10-Q) is open in full — no account needed.
Partner
Trade OSTX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify